Crosstalk Between Sirt1 Activators And Nf-?b Axis As A Therapeutic Target To Reduce Pancreatic Cancer
Abstract
Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani.
The cellular availability of NAD+ is essential for Sirtuin 1 (SIRT1), a class III histone deacetylase, catalytic activity which make it as a reliable metabolic sensor. For evidence, SIRT1 had a high expression in tissue with metabolic activity including muscle, brain, liver, pancreas, and adipose tissue. Previous reports have documented the crosstalk between SIRT1 and nuclear factor kappa-B (NF-κB) signaling in conditions such as lymphoma, leukemia, and myeloma. The purpose of present study is to find the relationships between SIRT1 and NF-κB activation on pancreatic cancer cells (Capan-2, AsPC-1, and BxPC-3). We found the activation of NF-κB was inhibited by use 1 µM SIRT1 aptamer by increased the activity of SIRT1 protein. Overall, our findings suggested that SIRT1 activation resulting in inhibition of pancreatic cancer cells growth and significantly repression of NF-κB proteins activation, this activation of SIRT1 by aptamer may be considered as a potential future therapy for cancer especially pancreatic cancer.
| How to Cite this Article |
| Pubmed Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. SRP. 2021; 12(3): 207-212. doi:10.31838/srp.2021.3.34 Web Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. http://www.sysrevpharm.org/?mno=51635 [Access: March 30, 2021]. doi:10.31838/srp.2021.3.34 AMA (American Medical Association) Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. SRP. 2021; 12(3): 207-212. doi:10.31838/srp.2021.3.34 Vancouver/ICMJE Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. SRP. (2021), [cited March 30, 2021]; 12(3): 207-212. doi:10.31838/srp.2021.3.34 Harvard Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani (2021) Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. SRP, 12 (3), 207-212. doi:10.31838/srp.2021.3.34 Turabian Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. 2021. Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. Systematic Reviews in Pharmacy, 12 (3), 207-212. doi:10.31838/srp.2021.3.34 Chicago Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. "Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer." Systematic Reviews in Pharmacy 12 (2021), 207-212. doi:10.31838/srp.2021.3.34 MLA (The Modern Language Association) Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. "Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer." Systematic Reviews in Pharmacy 12.3 (2021), 207-212. Print. doi:10.31838/srp.2021.3.34 APA (American Psychological Association) Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani (2021) Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. Systematic Reviews in Pharmacy, 12 (3), 207-212. doi:10.31838/srp.2021.3.34 |
Abstract
PDF
How to cite this article
Related Records